Clinical trial
Long Term Follow-up of Immunological Pattern and Pregnancy Outcomes in Women Previously Enrolled in a Phase 1b Clinical Trial With the PRIMVAC Placental Malaria Candidate Vaccine
NCT05426187 is registered in ClinicalTrials.gov with Groupe de Recherche Action en Sante as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long Term Follow-up of Immunological Pattern and Pregnancy Outcomes in Women Previously Enrolled in a Phase 1b Clinical Trial With the PRIMVAC Placental Malaria Candidate Vaccine
- Lead sponsor
- Groupe de Recherche Action en Sante
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 18, 2022
- Completion date
- December 31, 2024
- Enrollment
- 90 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
malaria in pregnancy